Researchers are developing an off-the-shelf CAR-NKT therapy that targets various types of cancer, including ovarian cancer. The therapy, which has shown promise in targeting solid tumors, is also being explored for its potential to treat other cancers, such as pancreatic and breast cancer. Its effectiveness and application across different cancer types are still being studied and guided by various research and advisory efforts.